Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +153.9% | +80.4% | 3 / 3 | +7.6% | +0.32 pp | +5.12 pp | +13.4% | 0.42 | 8.50 | 160 | +7,6% | 14,2 | +153,9% | 8.50 | 10.26 | −17,2% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 16.900 (close price on 2026-10-13)EPS (TTM): 1.988
Financial charts
1.Revenue & growth
VND bn160Q2/26
1.Revenue & growth
VND bn160Q2/26
2.Profit & growth
VND bn14,2Q2/26
3.Profit mix (Penman)
VND bn79,8Q2/26
4.Margins & cost structure
%27.2%Q2/26
5.Returns & cash cycle
% · days10.8%Q2/26
6.Earnings quality & cash
VND bn185Q2/26
7.Asset structure
VND bn935Q2/26
8.Funding & debt health
VND bn · times935Q2/26
9.Revenue backlog
VND bn1,64Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %445Q2/26
Adjusted EPS growth, latest quarter
154%
Average adjusted EPS growth, 3 quarters
80.4%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26